Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 336

1.

Dietary Fat and Blood Pressure.

Nestel PJ.

Curr Hypertens Rep. 2019 Feb 12;21(2):17. doi: 10.1007/s11906-019-0918-y. Review.

PMID:
30747320
2.

Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials.

Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S.

Lancet. 2018 Oct 13;392(10155):1311-1320. doi: 10.1016/S0140-6736(18)31652-0. Epub 2018 Oct 4.

PMID:
30293769
3.

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention.

Mundra PA, Barlow CK, Nestel PJ, Barnes EH, Kirby A, Thompson P, Sullivan DR, Alshehry ZH, Mellett NA, Huynh K, Jayawardana KS, Giles C, McConville MJ, Zoungas S, Hillis GS, Chalmers J, Woodward M, Wong G, Kingwell BA, Simes J, Tonkin AM, Meikle PJ; LIPID Study Investigators.

JCI Insight. 2018 Sep 6;3(17). pii: 121326. doi: 10.1172/jci.insight.121326. eCollection 2018 Sep 6.

4.

D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease.

Simes J, Robledo KP, White HD, Espinoza D, Stewart RA, Sullivan DR, Zeller T, Hague W, Nestel PJ, Glasziou PP, Keech AC, Elliott J, Blankenberg S, Tonkin AM; LIPID Study Investigators.

Circulation. 2018 Aug 14;138(7):712-723. doi: 10.1161/CIRCULATIONAHA.117.029901.

PMID:
29367425
5.

Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome.

Khan AA, Mundra PA, Straznicky NE, Nestel PJ, Wong G, Tan R, Huynh K, Ng TW, Mellett NA, Weir JM, Barlow CK, Alshehry ZH, Lambert GW, Kingwell BA, Meikle PJ.

Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):438-447. doi: 10.1161/ATVBAHA.117.310212. Epub 2017 Dec 28.

PMID:
29284607
6.

Predictors of incident heart failure in patients after an acute coronary syndrome: The LIPID heart failure risk-prediction model.

Driscoll A, Barnes EH, Blankenberg S, Colquhoun DM, Hunt D, Nestel PJ, Stewart RA, West MJ, White HD, Simes J, Tonkin A.

Int J Cardiol. 2017 Dec 1;248:361-368. doi: 10.1016/j.ijcard.2017.06.098. Epub 2017 Jun 30.

PMID:
28728851
7.

Persistent psychological distress and mortality in patients with stable coronary artery disease.

Stewart RAH, Colquhoun DM, Marschner SL, Kirby AC, Simes J, Nestel PJ, Glozier N, O'Neil A, Oldenburg B, White HD, Tonkin AM; LIPID Study Investigators.

Heart. 2017 Dec;103(23):1860-1866. doi: 10.1136/heartjnl-2016-311097. Epub 2017 Jun 26.

PMID:
28652315
8.

Neck Circumference Is Associated with Muscle Sympathetic Nerve Activity in Overweight and Obese Men but Not Women.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Nestel PJ, Dixon JB, Lambert GW, Schlaich MP, Phillips SE, Lambert EA.

Front Physiol. 2017 Apr 6;8:203. doi: 10.3389/fphys.2017.00203. eCollection 2017.

9.

Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects.

Nestel PJ, Khan AA, Straznicky NE, Mellett NA, Jayawardana K, Mundra PA, Lambert GW, Meikle PJ.

Atherosclerosis. 2017 Jan;256:21-28. doi: 10.1016/j.atherosclerosis.2016.11.032. Epub 2016 Dec 1.

PMID:
27940403
10.

Plasma Lipidomic Profiles Improve on Traditional Risk Factors for the Prediction of Cardiovascular Events in Type 2 Diabetes Mellitus.

Alshehry ZH, Mundra PA, Barlow CK, Mellett NA, Wong G, McConville MJ, Simes J, Tonkin AM, Sullivan DR, Barnes EH, Nestel PJ, Kingwell BA, Marre M, Neal B, Poulter NR, Rodgers A, Williams B, Zoungas S, Hillis GS, Chalmers J, Woodward M, Meikle PJ.

Circulation. 2016 Nov 22;134(21):1637-1650. Epub 2016 Oct 18.

PMID:
27756783
11.

Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.

Hague WE, Simes J, Kirby A, Keech AC, White HD, Hunt D, Nestel PJ, Colquhoun DM, Pater H, Stewart RA, Sullivan DR, Thompson PL, West M, Glasziou PP, Tonkin AM; LIPID study investigators†.

Circulation. 2016 May 10;133(19):1851-60. doi: 10.1161/CIRCULATIONAHA.115.018580. Epub 2016 Mar 25. Review.

PMID:
27016105
12.

Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.

Straznicky NE, Grima MT, Sari CI, Lambert EA, Phillips SE, Eikelis N, Kobayashi D, Hering D, Mariani JA, Dixon JB, Nestel PJ, Karapanagiotidis S, Schlaich MP, Lambert GW.

Cardiovasc Diabetol. 2015 Aug 22;14:113. doi: 10.1186/s12933-015-0276-2.

13.

Postprandial Plasma Phospholipids in Men Are Influenced by the Source of Dietary Fat.

Meikle PJ, Barlow CK, Mellett NA, Mundra PA, Bonham MP, Larsen A, Cameron-Smith D, Sinclair A, Nestel PJ, Wong G.

J Nutr. 2015 Sep;145(9):2012-8. doi: 10.3945/jn.115.210104. Epub 2015 Jul 15.

PMID:
26180244
14.

Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert GW, Nestel PJ, Richards K, Dixon JB, Schlaich MP, Lambert EA.

Metabolism. 2015 Jul;64(7):797-803. doi: 10.1016/j.metabol.2015.03.006. Epub 2015 Mar 18.

PMID:
25827058
15.

Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.

Straznicky NE, Grima MT, Lambert EA, Sari CI, Eikelis N, Nestel PJ, Phillips SE, Hering D, Karapanagiotidis S, Dixon JB, Schlaich MP, Lambert GW.

J Clin Endocrinol Metab. 2015 Apr;100(4):1544-50. doi: 10.1210/jc.2014-3796. Epub 2015 Jan 15.

PMID:
25590214
16.

A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert GW, Nestel PJ, Karapanagiotidis S, Wong C, Richards K, Marusic P, Dixon JB, Schlaich MP, Lambert EA.

J Clin Endocrinol Metab. 2014 Sep;99(9):E1701-7. doi: 10.1210/jc.2014-1976. Epub 2014 Jun 17.

PMID:
24937541
17.

Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity.

Nestel PJ, Straznicky N, Mellett NA, Wong G, De Souza DP, Tull DL, Barlow CK, Grima MT, Meikle PJ.

Am J Clin Nutr. 2014 Jan;99(1):46-53. doi: 10.3945/ajcn.113.071712. Epub 2013 Oct 23.

PMID:
24153346
18.

Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.

Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR.

Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2902-8. doi: 10.1161/ATVBAHA.113.302479. Epub 2013 Oct 3.

PMID:
24092750
19.

The effects of dietary weight loss on indices of norepinephrine turnover: modulatory influence of hyperinsulinemia.

Straznicky NE, Lambert EA, Grima MT, Eikelis N, Richards K, Nestel PJ, Dawood T, Masuo K, Sari CI, Dixon JB, Esler MD, Paul E, Schlaich MP, Lambert GW.

Obesity (Silver Spring). 2014 Mar;22(3):652-62. doi: 10.1002/oby.20614. Epub 2013 Dec 6.

20.

Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults.

Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ.

Br J Nutr. 2013 Dec;110(12):2242-9. doi: 10.1017/S0007114513001621. Epub 2013 Jun 12.

PMID:
23756569
21.

Perspective: nonalcoholic fatty liver disease and cardiovascular risk.

Nestel PJ, Mensink RP.

Curr Opin Lipidol. 2013 Feb;24(1):1-3. doi: 10.1097/MOL.0b013e32835c0834.

PMID:
23298957
22.

The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.

Straznicky NE, Grima MT, Sari CI, Karapanagiotidis S, Wong C, Eikelis N, Richards KL, Lee G, Nestel PJ, Dixon JB, Lambert GW, Schlaich MP, Lambert EA.

J Clin Endocrinol Metab. 2013 Feb;98(2):E227-37. doi: 10.1210/jc.2012-3277. Epub 2012 Dec 27.

PMID:
23271752
23.

Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.

Chan DC, Hoang A, Barrett PH, Wong AT, Nestel PJ, Sviridov D, Watts GF.

J Clin Endocrinol Metab. 2012 Sep;97(9):E1658-66. doi: 10.1210/jc.2012-1522. Epub 2012 Jun 28.

PMID:
22745238
24.

Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.

Straznicky NE, Grima MT, Sari CI, Eikelis N, Lambert EA, Nestel PJ, Esler MD, Dixon JB, Chopra R, Tilbrook AJ, Schlaich MP, Lambert GW.

Diabetes. 2012 Oct;61(10):2506-16. Epub 2012 Jun 4.

25.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ.

JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366. Erratum in: JAMA. 2012 May 9;307(18):1915. JAMA. 2012 Apr 25;307(16):1694.

PMID:
22453571
26.

Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.

Tan HC, Tai ES, Sviridov D, Nestel PJ, Ng C, Chan E, Teo Y, Wai DC.

J Clin Lipidol. 2011 Nov-Dec;5(6):467-73. doi: 10.1016/j.jacl.2011.06.016. Epub 2011 Jun 28.

PMID:
22108150
27.

Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects.

Straznicky NE, Eikelis N, Nestel PJ, Dixon JB, Dawood T, Grima MT, Sari CI, Schlaich MP, Esler MD, Tilbrook AJ, Lambert GW, Lambert EA.

J Clin Endocrinol Metab. 2012 Feb;97(2):605-13. doi: 10.1210/jc.2011-2320. Epub 2011 Nov 16.

PMID:
22090279
28.

The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects.

Straznicky NE, Lambert EA, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Masuo K, Chopra R, Sari CI, Dixon JB, Tilbrook AJ, Lambert GW.

Diabetes Obes Metab. 2012 Feb;14(2):139-48. doi: 10.1111/j.1463-1326.2011.01497.x. Epub 2011 Nov 3.

PMID:
21923735
29.

Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods.

Nestel PJ, Pally S, MacIntosh GL, Greeve MA, Middleton S, Jowett J, Meikle PJ.

Eur J Clin Nutr. 2012 Jan;66(1):25-31. doi: 10.1038/ejcn.2011.134. Epub 2011 Aug 3.

PMID:
21811291
30.

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

Straznicky NE, Grima MT, Eikelis N, Nestel PJ, Dawood T, Schlaich MP, Chopra R, Masuo K, Esler MD, Sari CI, Lambert GW, Lambert EA.

J Clin Endocrinol Metab. 2011 Mar;96(3):E503-8. doi: 10.1210/jc.2010-2204. Epub 2010 Dec 22.

PMID:
21177786
31.

Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals.

Straznicky NE, Grima MT, Lambert EA, Eikelis N, Dawood T, Lambert GW, Nestel PJ, Masuo K, Sari CI, Chopra R, Mariani JA, Schlaich MP.

J Hypertens. 2011 Mar;29(3):553-64. doi: 10.1097/HJH.0b013e3283418875.

PMID:
21119532
32.

Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects.

Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW.

Diabetes. 2010 Jan;59(1):71-9. doi: 10.2337/db09-0934. Epub 2009 Oct 15.

33.

Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome.

Straznicky NE, Lambert GW, McGrane MT, Masuo K, Dawood T, Nestel PJ, Eikelis N, Schlaich MP, Esler MD, Socratous F, Chopra R, Lambert EA.

Diabetes. 2009 May;58(5):1126-32. doi: 10.2337/db08-1595. Epub 2009 Feb 2.

34.

Effects of dairy fats within different foods on plasma lipids.

Nestel PJ.

J Am Coll Nutr. 2008 Dec;27(6):735S-40S. Review.

PMID:
19155433
35.

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

Straznicky NE, Lambert GW, Masuo K, Dawood T, Eikelis N, Nestel PJ, McGrane MT, Mariani JA, Socratous F, Chopra R, Esler MD, Schlaich MP, Lambert EA.

Am J Clin Nutr. 2009 Jan;89(1):27-36. doi: 10.3945/ajcn.2008.26299. Epub 2008 Dec 3.

PMID:
19056585
36.

Management of dyslipidaemia - evidence and practical recommendations.

Nestel PJ, O'Brien R, Nelson M.

Aust Fam Physician. 2008 Jul;37(7):521-7. Review.

PMID:
18592069
37.

Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome.

Ooi EM, Watts GF, Chan DC, Chen MM, Nestel PJ, Sviridov D, Barrett PH.

Diabetes Care. 2008 Aug;31(8):1656-61. doi: 10.2337/dc08-0358. Epub 2008 May 28.

38.

The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.

West MJ, Nestel PJ, Kirby AC, Schnabel R, Sullivan D, Simes RJ, Pollicino C, Lubos E, Münzel TF, White HD, Tonkin AM, Bickel C, Tiret L, Blankenberg S; LIPID Study Investigators.

Eur Heart J. 2008 Apr;29(7):923-31. doi: 10.1093/eurheartj/ehn007. Epub 2008 Feb 22.

PMID:
18296678
39.

Dietary plant sterols supplementation does not alter lipoprotein kinetics in men with the metabolic syndrome.

Ooi EM, Watts GF, Barrett PH, Chan DC, Clifton PM, Ji J, Nestel PJ.

Asia Pac J Clin Nutr. 2007;16(4):624-31.

40.

Dose-dependent regulation of high-density lipoprotein metabolism with rosuvastatin in the metabolic syndrome.

Ooi EM, Watts GF, Nestel PJ, Sviridov D, Hoang A, Barrett PH.

J Clin Endocrinol Metab. 2008 Feb;93(2):430-7. Epub 2007 Nov 20.

41.

Dose-dependent effect of rosuvastatin on apolipoprotein B-100 kinetics in the metabolic syndrome.

Ooi EM, Barrett PH, Chan DC, Nestel PJ, Watts GF.

Atherosclerosis. 2008 Mar;197(1):139-46. Epub 2007 Apr 9.

PMID:
17416370
42.

Genetic factors affecting HDL levels, structure, metabolism and function.

Sviridov D, Nestel PJ.

Curr Opin Lipidol. 2007 Apr;18(2):157-63. Review.

PMID:
17353664
43.

Management of dyslipidaemia in patients with type 2 diabetes in Australian primary care.

Thomas MC, Nestel PJ.

Med J Aust. 2007 Feb 5;186(3):128-30.

PMID:
17309401
44.

Dietary supplementation with chickpeas for at least 5 weeks results in small but significant reductions in serum total and low-density lipoprotein cholesterols in adult women and men.

Pittaway JK, Ahuja KD, Cehun M, Chronopoulos A, Robertson IK, Nestel PJ, Ball MJ.

Ann Nutr Metab. 2006;50(6):512-8. Epub 2006 Dec 21.

PMID:
17191025
45.

A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.

Fujii A, Allen TJ, Nestel PJ.

Atherosclerosis. 2007 Jul;193(1):55-61. Epub 2006 Sep 22.

PMID:
16996521
46.

Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.

Watts GF, Chan DC, Ooi EM, Nestel PJ, Beilin LJ, Barrett PH.

Clin Exp Pharmacol Physiol. 2006 Sep;33(9):877-82. Review.

PMID:
16922825
47.

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.

Straznicky NE, Lambert EA, Lambert GW, Masuo K, Esler MD, Nestel PJ.

J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005. Epub 2005 Aug 9.

PMID:
16091482
48.

Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects.

Nestel PJ, Chronopulos A, Cehun M.

Eur J Clin Nutr. 2005 Sep;59(9):1059-63.

PMID:
16015270
49.

Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.

Nestel PJ, Baghurst K, Colquhoun DM, Simes RJ, Mehalski K, White HD, Tonkin AM, Kirby A, Pollicino C; Long-Term Intervention with Pravastatin in Ischaemic Disease Study Investigators.

Am J Clin Nutr. 2005 Jun;81(6):1322-9.

PMID:
15941882
50.

White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.

Stewart RA, White HD, Kirby AC, Heritier SR, Simes RJ, Nestel PJ, West MJ, Colquhoun DM, Tonkin AM; Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators.

Circulation. 2005 Apr 12;111(14):1756-62. Epub 2005 Apr 4.

PMID:
15809366

Supplemental Content

Loading ...
Support Center